Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 07, 2026 01:00 ET | Source: Sanofi Winthrop Industrie

Communiqué de presse: Le lunsekimig de Sanofi a atteint les critères d’évaluation principal et secondaires clés dans les études respiratoires de phase 2 dans l’asthme et la rhinosinusite chronique avec polypose nasale

Des études de phase 2 sur le lunsekimig ont atteint les critères d’évaluation principaux et secondaires clés dans deux maladies respiratoires
April 07, 2026 01:00 ET | Source: Sanofi Winthrop Industrie

Press Release: Sanofi’s lunsekimig met primary and key secondary endpoints in phase 2 respiratory studies in asthma and CRSwNP

Phase 2 studies of lunsekimig, a novel bispecific nanobody, met primary and key secondary endpoints in two chronic respiratory conditions.
October 27, 2025 20:04 ET | Source: DiCello Levitt LLP

SHAREHOLDER ALERT: DiCello Levitt LLP Announces That A Shareholder Class Action Has Been Filed Against MoonLake Immunotherapeutics (NASDAQ: MLTX)

DiCello Levitt LLP: MoonLake investors wishing to serve as lead plaintiff have until December 15, 2025, to petition the Court.
November 30, 2022 10:15 ET | Source: Market Research Future

Nanobody Market Size to Surpass USD 1.14 Billion by 2030 at 24.2% CAGR – Report by Market Research Future (MRFR)

New York, USA, Nov. 30, 2022 (GLOBE NEWSWIRE) -- Nanobody Market Overview: According to a Comprehensive Research Report by Market Research Future (MRFR), “Nanobody Market Analysis by Type,...
August 12, 2020 09:30 ET | Source: Beroni Group Limited

Beroni Group Signs Agreement with Genscript Biotech Corporation to Conduct Further Study to Develop Nanobody-based Medical Solution for COVID-19

NEW YORK and SYDNEY, Australia, Aug. 12, 2020 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), is pleased to announce that further to its announcement on August...
March 29, 2012 16:00 ET | Source: American Heart Association

Radioactive Antibody Fragment May Help Scientists Identify Artery Deposits

Study Highlights: Creating a tiny, radioactive antibody fragment may help scientists identify artery deposits most likely to burst and cause a heart attack. A non-invasive system uses...